"Whether it's GLP-1 or desire for proteins, Tapatío and hot sauces enhance that experience. The uptick in sales reflects a shift in consumer preferences towards bolder flavors."
"[E]ven consumers who aren't on GLP-1s recognize that there needs to be an off-switch for 'food noise,' and the answer is a massive dose of protein."
GLP-1 drugs, known for reducing appetite, have unexpectedly boosted sales for hot sauce manufacturers like Tapatío. Consumers using these drugs are seeking bolder taste experiences. The trend is not limited to GLP-1 users; the popularity of high-protein foods is rising among all consumers. This convergence in food trends may lead to further consolidation in the hot sauce industry, as seen with the recent merger of McCormick and Unilever Foods, suggesting potential for more industry deals as GLP-1 adoption grows.
Read at InsideHook
Unable to calculate read time
Collection
[
|
...
]